Provided by Tiger Trade Technology Pte. Ltd.

Immunome Inc.

27.57
-1.3000-4.50%
Volume:784.51K
Turnover:21.73M
Market Cap:3.13B
PE:-11.09
High:28.77
Open:28.45
Low:27.40
Close:28.87
52wk High:30.06
52wk Low:8.67
Shares:113.58M
Float Shares:108.11M
Volume Ratio:0.68
T/O Rate:0.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4851
EPS(LYR):-2.4315
ROE:-64.03%
ROA:-37.78%
PB:5.96
PE(LYR):-11.34

Loading ...

Craig-Hallum Keeps Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
Apr 29

Immunome submits FDA NDA for varegacestat in adult desmoid tumors

Reuters
·
Apr 29

Immunome Announces Submission of New Drug Application to U.S. FDA for Varegacestat for the Treatment of Adults With Desmoid Tumors

THOMSON REUTERS
·
Apr 29

Immunome announces annual shareholder meeting webcast

Reuters
·
Apr 25

Immunome to present Phase 3 RINGSIDE desmoid tumor data in ASCO oral session

Reuters
·
Apr 21

Immunome Announces Oral Presentation of Phase 3 Ringside Data at 2026 Asco Annual Meeting

THOMSON REUTERS
·
Apr 21

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Immunome (IMNM) and Eli Lilly & Co (LLY)

TIPRANKS
·
Apr 17

Immunome (IMNM) Receives a Buy from LifeSci Capital

TIPRANKS
·
Apr 07

Immunome CSO Jack Higgins disposes of $0.2 million common shares

Reuters
·
Apr 04

Immunome CFO Max Rosett disposes of common shares worth 1.4 million

Reuters
·
Apr 04

BRIEF-Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 03

Immunome grants inducement stock options for 188,500 shares to 13 new hires

Reuters
·
Apr 03

Immunome CEO Clay Siegall buys $0.5 million in common shares

Reuters
·
Apr 01

Immunome Director Philip Wagenheim Disposes of Common Shares Worth USD 1,335,000

Reuters
·
Mar 24

Immunome Director Jean Jacques Bienaime Acquires Common Shares

Reuters
·
Mar 12

Immunome Grants 282,000 Inducement Stock Options to New Hires

Reuters
·
Mar 06

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Mar 06

Stock Track | Immunome Inc. Soars 5.43% Intraday on Multiple Positive Analyst Actions

Stock Track
·
Mar 04

Immunome Is Maintained at Overweight by Stephens & Co.

Dow Jones
·
Mar 04

Piper Sandler Sticks to Its Buy Rating for Immunome (IMNM)

TIPRANKS
·
Mar 04